| 000 | 01476 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515070441.0 | ||
| 264 | 0 | _c20070820 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1007-9327 | ||
| 024 | 7 |
_a10.3748/wjg.v13.i16.2328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeyrin-Biroulet, Laurent | |
| 245 | 0 | 0 |
_aAdalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study. _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cApr 2007 |
||
| 300 |
_a2328-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xblood |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 700 | 1 | _aLaclotte, Cécile | |
| 700 | 1 | _aRoblin, Xavier | |
| 700 | 1 | _aBigard, Marc-André | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 13 _gno. 16 _gp. 2328-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v13.i16.2328 _zAvailable from publisher's website |
| 999 |
_c17055184 _d17055184 |
||